171 related articles for article (PubMed ID: 20455383)
1. [Pathogenesis of atopic dermatitis].
Lang C; Kypriotou M; Christen-Zaech S
Rev Med Suisse; 2010 Apr; 6(246):860-2, 864-5. PubMed ID: 20455383
[TBL] [Abstract][Full Text] [Related]
2. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis.
Margolis DJ; Kim B; Apter AJ; Gupta J; Hoffstad O; Papadopoulos M; Mitra N
JAMA Dermatol; 2014 Mar; 150(3):254-9. PubMed ID: 24401911
[TBL] [Abstract][Full Text] [Related]
3. IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.
Bernard M; Carrasco C; Laoubi L; Guiraud B; Rozières A; Goujon C; Duplan H; Bessou-Touya S; Nicolas JF; Vocanson M; Galliano MF
J Pathol; 2017 Jun; 242(2):234-245. PubMed ID: 28191908
[TBL] [Abstract][Full Text] [Related]
4. Genetics of atopic dermatitis: beyond filaggrin-the role of thymic stromal lymphopoietin in disease persistence.
Duchatelet S; Hovnanian A
JAMA Dermatol; 2014 Mar; 150(3):248-50. PubMed ID: 24402650
[No Abstract] [Full Text] [Related]
5. Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age.
Wan J; Mitra N; Hoffstad OJ; Margolis DJ
Ann Allergy Asthma Immunol; 2017 Jun; 118(6):737-738.e1. PubMed ID: 28479194
[No Abstract] [Full Text] [Related]
6. Immune-mediated Skin Inflammation is Similar in Severe Atopic Dermatitis Patients With or Without Filaggrin Mutation.
Dajnoki Z; Béke G; Mócsai G; Kapitány A; Gáspár K; Hajdu K; Emri G; Nagy B; Kovács I; Beke L; Dezső B; Szegedi A
Acta Derm Venereol; 2016 Jun; 96(5):645-50. PubMed ID: 26536977
[TBL] [Abstract][Full Text] [Related]
7. Skin pH Is the Master Switch of Kallikrein 5-Mediated Skin Barrier Destruction in a Murine Atopic Dermatitis Model.
Jang H; Matsuda A; Jung K; Karasawa K; Matsuda K; Oida K; Ishizaka S; Ahn G; Amagai Y; Moon C; Kim SH; Arkwright PD; Takamori K; Matsuda H; Tanaka A
J Invest Dermatol; 2016 Jan; 136(1):127-35. PubMed ID: 26763432
[TBL] [Abstract][Full Text] [Related]
8. Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function.
Yamada K; Matsushita K; Wang J; Kanekura T
Acta Derm Venereol; 2018 Jan; 98(1):19-25. PubMed ID: 28967978
[TBL] [Abstract][Full Text] [Related]
9. Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis.
Mócsai G; Gáspár K; Nagy G; Irinyi B; Kapitány A; Bíró T; Gyimesi E; Tóth B; Maródi L; Szegedi A
Br J Dermatol; 2014 Mar; 170(3):617-24. PubMed ID: 24251354
[TBL] [Abstract][Full Text] [Related]
10. Association of Filaggrin Loss of Function and Thymic Stromal Lymphopoietin Variation With Treatment Use in Pediatric Atopic Dermatitis.
Chang J; Mitra N; Hoffstad O; Margolis DJ
JAMA Dermatol; 2017 Mar; 153(3):275-281. PubMed ID: 27902816
[TBL] [Abstract][Full Text] [Related]
11. IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.
Floudas A; Saunders SP; Moran T; Schwartz C; Hams E; Fitzgerald DC; Johnston JA; Ogg GS; McKenzie AN; Walsh PT; Fallon PG
J Immunol; 2017 Jul; 199(2):707-717. PubMed ID: 28615416
[TBL] [Abstract][Full Text] [Related]
12. The association between phthalate exposure and atopic dermatitis with a discussion of phthalate induced secretion of interleukin-1β and thymic stromal lymphopoietin.
Overgaard LE; Bonefeld CM; Frederiksen H; Main KM; Thyssen JP
Expert Rev Clin Immunol; 2016 Jun; 12(6):609-16. PubMed ID: 26894419
[TBL] [Abstract][Full Text] [Related]
13. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations.
Jakasa I; Koster ES; Calkoen F; McLean WH; Campbell LE; Bos JD; Verberk MM; Kezic S
J Invest Dermatol; 2011 Feb; 131(2):540-2. PubMed ID: 20962854
[No Abstract] [Full Text] [Related]
14. Acidification of stratum corneum prevents the progression from atopic dermatitis to respiratory allergy.
Lee HJ; Lee NR; Kim BK; Jung M; Kim DH; Moniaga CS; Kabashima K; Choi EH
Exp Dermatol; 2017 Jan; 26(1):66-72. PubMed ID: 27376923
[TBL] [Abstract][Full Text] [Related]
15. The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.
Liang Y; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Dec; 51(3):315-328. PubMed ID: 26385242
[TBL] [Abstract][Full Text] [Related]
16. The role of filaggrin loss-of-function mutations in atopic dermatitis.
O'Regan GM; Irvine AD
Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):406-10. PubMed ID: 18769192
[TBL] [Abstract][Full Text] [Related]
17. Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice.
Moniaga CS; Jeong SK; Egawa G; Nakajima S; Hara-Chikuma M; Jeon JE; Lee SH; Hibino T; Miyachi Y; Kabashima K
Am J Pathol; 2013 Mar; 182(3):841-51. PubMed ID: 23333753
[TBL] [Abstract][Full Text] [Related]
18. Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice.
Kim YJ; Choi MJ; Bak DH; Lee BC; Ko EJ; Ahn GR; Ahn SW; Kim MJ; Na J; Kim BJ
Sci Rep; 2018 Aug; 8(1):11895. PubMed ID: 30093649
[TBL] [Abstract][Full Text] [Related]
19. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.
Kelleher M; Dunn-Galvin A; Hourihane JO; Murray D; Campbell LE; McLean WHI; Irvine AD
J Allergy Clin Immunol; 2015 Apr; 135(4):930-935.e1. PubMed ID: 25618747
[TBL] [Abstract][Full Text] [Related]
20. Skin barrier in atopic dermatitis.
Kezic S; Novak N; Jakasa I; Jungersted JM; Simon M; Brandner JM; Middelkamp-Hup MA; Weidinger S
Front Biosci (Landmark Ed); 2014 Jan; 19(3):542-56. PubMed ID: 24389202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
